Product Information
TAMSULOSIN HCL 0.4 MG CAPSULE is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.0500 per EA under NDC 76282074490. Its NADAC has been published 52 times since Oct 8, 2025.
FDA first approved this application on Apr 27, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.4 mg/1
Manufacturer
Exelan Pharmaceuticals Inc.NDC
76282074490
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TAMSULOSIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078801FDA Approved
4/27/2010
TE Code
AB
On Market Since
3/1/2024
Pharmacological Classes
Price Statistics
The NADAC for TAMSULOSIN HCL 0.4 MG CAPSULE has been published 52 times since Oct 8, 2025, and over the history we have for it it has declined 2.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0500 per EA |
|---|---|
| All-time high | $0.0522 (Mar 11, 2026) |
| All-time low | $0.0494 (May 20, 2026) |
| 52-week high | $0.0522 |
| 52-week low | $0.0494 |
| Median price | $0.0505 |
| Average price | $0.0507 |
| Largest weekly change | +2.7% (Aug 19, 2026) |
| Weeks tracked | 52 |
| Tracking since | Oct 8, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Exelan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tamsulosin hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TAMSULOSIN HCL 0.4 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TAMSULOSIN HCL 0.4 MG CAPSULE, manufactured by Exelan Pharmaceuticals Inc., is $0.0500 per EA (NDC 76282074490), effective Sep 30, 2026.
How has the price of TAMSULOSIN HCL 0.4 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TAMSULOSIN HCL 0.4 MG CAPSULE has declined 2.4%. It has been tracked across 52 weekly CMS publications since Oct 8, 2025.
What are the highest and lowest recorded NADAC prices for TAMSULOSIN HCL 0.4 MG CAPSULE?
Since Oct 8, 2025, the NADAC for TAMSULOSIN HCL 0.4 MG CAPSULE has ranged from a low of $0.0494 (May 20, 2026) to a high of $0.0522 (Mar 11, 2026), with a median of $0.0505 per EA.
Are there cheaper alternatives to TAMSULOSIN HCL 0.4 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TAMSULOSIN HCL 0.4 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures TAMSULOSIN HCL 0.4 MG CAPSULE?
TAMSULOSIN HCL 0.4 MG CAPSULE (NDC 76282074490) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.